Study analysis · BMJ Global Health · 2021
Zinc won't stop you from catching a cold, but it can slash your symptoms by nearly half – here's what the science actually says.
Taking vitamin D or C might slightly lower your chance of getting a cold, and if you start zinc when sick, you could feel better much faster, but the benefits are smaller than you think.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study combined many good experiments where people were randomly given vitamins or fake pills. It found that vitamins might help a little bit in preventing colds and making them shorter, but the help is small. So we can say they might work, but we can't say they definitely prevent or cure colds.
What’s the bottom line?
Researchers looked at many studies where adults took vitamin D, vitamin C, or zinc supplements to see if they prevented or shortened colds and flu. They found small effects: vitamin D and C slightly lowered the chance of getting sick, and zinc (when taken after getting sick) shortened symptoms a lot. But the results weren't very strong or consistent.
How strong is this study?
The researchers looked at many experiments, but some of those experiments weren't perfect—like not being sure who got the real vitamin. That means we have to be a bit careful about trusting the results completely. Overall, it's a well-done summary, but the individual studies could be better.
75 / 100
- COI disclosure+40/40
- Data availability+35/35
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 554 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. Although the review includes RCTs, which can establish causation, the modest effect sizes, heterogeneity, potential publication bias, and risk of bias in many included studies limit confidence in strong causal claims. The authors themselves rate the evidence as moderate.
No Conflicts
No conflicts of interest identified
No conflicts identified.
No COI or funding information provided in the text.
Key takeaways
- 01
Vitamin D reduced risk by 3% and shortened illness by 6%.
- 02
Vitamin C reduced risk by 4% and shortened illness by 9%.
- 03
Zinc did not prevent infection but shortened symptoms by 47%.
- 04
Note: study has corrections; check for updates.
- 05
The effects are small: for every 100 people, maybe 1-4 fewer get sick.
- 06
Zinc's big effect on duration comes from a few small studies with problems.
- 07
So don't rely on supplements alone.
Surprising findings
- Zinc supplementation does not reduce the risk of catching a cold (RR 1.06, p=0.31), but it dramatically shortens symptoms by 47%.Many people take zinc to prevent colds, but the data show no preventive effect. The treatment effect, while large, is based on a small number of studies with high heterogeneity and potential publication bias.
- Vitamin C's preventive effect was much stronger in men (18% risk reduction) than in women, and also stronger in middle-income countries (35%) than in high-income countries.We usually think of vitamin C as equally helpful for everyone, but this study finds that sex and country income level significantly modify the effect.
Practical takeaways
If you want to try vitamin D, take 2000 IU daily (and consider a starting loading dose under 60,000 IU once, but consult a doctor). For vitamin C, 1 gram daily might help, especially if you're a man or in a middle-income country. For zinc, start lozenges (13–23 mg) at the first sign of symptoms to shorten illness.
Effects are modest; don't expect dramatic results. Zinc may cause nausea. Studies had high heterogeneity and bias. This is not medical advice.
medium confidenceIf you are already deficient in a micronutrient, supplements will likely help more. Testing before supplementing could be useful.
Most studies did not measure baseline levels, so benefit may be limited to those with low status.
medium confidenceWhy this study matters
Vitamin D: A 3% risk reduction with a catch
Vitamin D supplements reduced the risk of acute respiratory infections by just 3% overall (RR 0.97). But when infections were confirmed by lab test or doctor diagnosis, the reduction jumped to 18%. The best dosing: at least 2000 IU daily with a loading dose under 60,000 IU.
Most people think vitamin D is a cold-fighter, but the real effect is tiny unless you're already deficient or get tested.
Vitamin C: Works better for men and in middle-income countries
Vitamin C lowered ARI risk by 4% overall (RR 0.96). Surprisingly, the effect was 18% in men and 35% in middle-income countries, but insignificant in women and high-income nations. Duration shortened by 9%.
We often treat vitamin C as a universal remedy, but this study suggests your sex and where you live matter more than the dose.
Zinc: The underdog that halves symptom duration
Zinc did not prevent colds at all (RR 1.06). But when taken during illness, it shortened symptoms by a whopping 47% – from about 7 days to under 4. However, this result comes from small studies with 'considerable' heterogeneity and possible publication bias.
Zinc's prevention myth is busted, but its treatment effect is huge – though we can't fully trust the number due to poor study quality.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Researchers looked at many studies where adults took vitamin D, vitamin C, or zinc supplements to see if they prevented or shortened colds and flu. They found small effects: vitamin D and C slightly lowered the chance of getting sick, and zinc (when taken after getting sick) shortened symptoms a lot. But the results weren't very strong or consistent.
Research results
Vitamin D reduced risk by 3% and shortened illness by 6%. Vitamin C reduced risk by 4% and shortened illness by 9%. Zinc did not prevent infection but shortened symptoms by 47%. Note: study has corrections; check for updates.
What this means - more context
The effects are small: for every 100 people, maybe 1-4 fewer get sick. Zinc's big effect on duration comes from a few small studies with problems. So don't rely on supplements alone.
Systematic review and meta-analysis of 80 RCTs examining effects of vitamin D, vitamin C, zinc, and multiple micronutrient supplements on prevention and duration of acute respiratory infections in adults. Note: This study has published corrections/errata; readers should check the correction notices for updated information.
Vitamin D (RR 0.97), vitamin C (RR 0.96) modestly reduced ARI risk; zinc did not (RR 1.06). Vitamin D shortened symptoms by 6%, vitamin C by 9%, zinc by 47%. Effects were stronger with clinical/lab-confirmed diagnosis (vitamin D), in men and middle-income countries (vitamin C). Zinc effect on duration had high heterogeneity and possible publication bias. Multiple micronutrient supplements showed inconsistent evidence.
Methods Used
Systematic review of Medline and EMBASE through March 2020; included RCTs on adults (mean age ≥18). Random effects meta-analyses pooled risk ratios for incidence and percentage differences for symptom duration. Subgroup and dose-response analyses performed.
Main Finding
Vitamin D and C modestly reduce ARI risk and shorten duration; zinc does not prevent but substantially shortens symptoms. Clinical meaningfulness unclear. Meta-analyses show small effect sizes with some heterogeneity.
Confidence Level
Moderate; based on systematic review of RCTs with mostly 'some concerns' or high risk of bias, substantial heterogeneity in some analyses, and possible publication bias.
Study Flags
Red Flags
- •High heterogeneity (I²=94%) and possible publication bias for zinc duration effect
- •Many included studies had high risk of bias or 'some concerns'
- •Most studies from high-income countries, limiting generalizability
Surprising Findings
Zinc supplementation does not reduce the risk of catching a cold (RR 1.06, p=0.31), but it dramatically shortens symptoms by 47%.
Many people take zinc to prevent colds, but the data show no preventive effect. The treatment effect, while large, is based on a small number of studies with high heterogeneity and potential publication bias.
Practical Takeaways
If you want to try vitamin D, take 2000 IU daily (and consider a starting loading dose under 60,000 IU once, but consult a doctor). For vitamin C, 1 gram daily might help, especially if you're a man or in a middle-income country. For zinc, start lozenges (13–23 mg) at the first sign of symptoms to shorten illness.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 554 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Human Meta-Analysis
Subject
Moderate probability
on the GRADE evidence scale
This study combined many good experiments where people were randomly given vitamins or fake pills. It found that vitamins might help a little bit in preventing colds and making them shorter, but the help is small. So we can say they might work, but we can't say they definitely prevent or cure colds.
The study has a COI section but no disclosure was found. A small penalty has been applied.
Strengths
- Systematic review with comprehensive search
- Meta-analysis with random effects
- Assessment of heterogeneity and publication bias
Weaknesses
- Many included studies had high risk of bias
- Heterogeneity in some analyses
- Potential publication bias for some outcomes
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Researchers looked at many studies where adults took vitamin D, vitamin C, or zinc supplements to see if they prevented or shortened colds and flu. They found small effects: vitamin D and C slightly lowered the chance of getting sick, and zinc (when taken after getting sick) shortened symptoms a lot. But the results weren't very strong or consistent.
Research results
Vitamin D reduced risk by 3% and shortened illness by 6%. Vitamin C reduced risk by 4% and shortened illness by 9%. Zinc did not prevent infection but shortened symptoms by 47%. Note: study has corrections; check for updates.
What this means - more context
The effects are small: for every 100 people, maybe 1-4 fewer get sick. Zinc's big effect on duration comes from a few small studies with problems. So don't rely on supplements alone.
Systematic review and meta-analysis of 80 RCTs examining effects of vitamin D, vitamin C, zinc, and multiple micronutrient supplements on prevention and duration of acute respiratory infections in adults. Note: This study has published corrections/errata; readers should check the correction notices for updated information.
Vitamin D (RR 0.97), vitamin C (RR 0.96) modestly reduced ARI risk; zinc did not (RR 1.06). Vitamin D shortened symptoms by 6%, vitamin C by 9%, zinc by 47%. Effects were stronger with clinical/lab-confirmed diagnosis (vitamin D), in men and middle-income countries (vitamin C). Zinc effect on duration had high heterogeneity and possible publication bias. Multiple micronutrient supplements showed inconsistent evidence.
Methods Used
Systematic review of Medline and EMBASE through March 2020; included RCTs on adults (mean age ≥18). Random effects meta-analyses pooled risk ratios for incidence and percentage differences for symptom duration. Subgroup and dose-response analyses performed.
Main Finding
Vitamin D and C modestly reduce ARI risk and shorten duration; zinc does not prevent but substantially shortens symptoms. Clinical meaningfulness unclear. Meta-analyses show small effect sizes with some heterogeneity.
Confidence Level
Moderate; based on systematic review of RCTs with mostly 'some concerns' or high risk of bias, substantial heterogeneity in some analyses, and possible publication bias.
Study Flags
Red Flags
- •High heterogeneity (I²=94%) and possible publication bias for zinc duration effect
- •Many included studies had high risk of bias or 'some concerns'
- •Most studies from high-income countries, limiting generalizability
Surprising Findings
Zinc supplementation does not reduce the risk of catching a cold (RR 1.06, p=0.31), but it dramatically shortens symptoms by 47%.
Many people take zinc to prevent colds, but the data show no preventive effect. The treatment effect, while large, is based on a small number of studies with high heterogeneity and potential publication bias.
Practical Takeaways
If you want to try vitamin D, take 2000 IU daily (and consider a starting loading dose under 60,000 IU once, but consult a doctor). For vitamin C, 1 gram daily might help, especially if you're a man or in a middle-income country. For zinc, start lozenges (13–23 mg) at the first sign of symptoms to shorten illness.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 554 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Human Meta-Analysis
Subject
Moderate probability
on the GRADE evidence scale
This study combined many good experiments where people were randomly given vitamins or fake pills. It found that vitamins might help a little bit in preventing colds and making them shorter, but the help is small. So we can say they might work, but we can't say they definitely prevent or cure colds.
The study has a COI section but no disclosure was found. A small penalty has been applied.
Strengths
- Systematic review with comprehensive search
- Meta-analysis with random effects
- Assessment of heterogeneity and publication bias
Weaknesses
- Many included studies had high risk of bias
- Heterogeneity in some analyses
- Potential publication bias for some outcomes
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The researchers looked at many experiments, but some of those experiments weren't perfect—like not being sure who got the real vitamin. That means we have to be a bit careful about trusting the results completely. Overall, it's a well-done summary, but the individual studies could be better.
75 / 100
- COI disclosure+40/40
- Data availability+35/35
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 554 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. Although the review includes RCTs, which can establish causation, the modest effect sizes, heterogeneity, potential publication bias, and risk of bias in many included studies limit confidence in strong causal claims. The authors themselves rate the evidence as moderate.
No Conflicts
No conflicts of interest identified
No conflicts identified.
No COI or funding information provided in the text.